CPhI China Success Provides Encouragement for 2021 Events and Boon for Industry

Pharmaceutical Technology Editors

CPhI China event organizers are encouraged by the success of the recent event and claim that it demonstrates a reassuring return to form for pharma events in 2021, which will also fuel a boom for the industry.

According to a Jan. 20, 2021 press release, CPhI China event organizers are encouraged by the success of the recent event and claim that it demonstrates a reassuring return to form for pharma events in 2021, which will also fuel a boom for the industry.

As reported in the release, the CPhI & P-MEC 2020 event attracted 46,157 visitors, including 5,105 international attendees. Among the companies exhibiting at the show were Pfizer, Sanofi, Capsugel, Dupont, Merck, BASF, Fosun Pharma, Hengrui Medicine, Yangtze River Pharmaceutical, and Fette.

“It was a tremendously successful event for pharma and an encouraging piece of news to start the year with, providing a window into what the post-pandemic exhibition environment can return to,” said Laura Murina, brand manager, Informa, in the press release. “2021 promises to be a celebration of the pharma industry with vaccine distribution now underway and we look forward to helping the industry meet both online and in person so it can continue its work in discovering and delivering vital therapies to patients.”

The 2020 event, which took place on Dec. 16–18, 2020, was a hybrid event comprising online and offline opportunities to learn about the latest industry developments and connect with peers. This year, the organizer has confirmed that the event will take place at the SNIEC between Dec. 16–18, 2021, and will also be a hybrid show.

Source: CPhI